Anthony Lucatorto
Family Medicine · Lake Hopatcong, NJNPI 1760443030
Payments from drug & device makers
Across 1,207 payments — averaging $14.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Novo Nordisk$2K
- AbbVie$2K
- Amgen$1K
- Arbor Pharmaceuticals, Inc.$692
- Bayer$679
- plus $7K from 39 others
What the payments were for
- Food & beverage$17,00398%
- Education$3012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,304 in reported general payments places this provider in the 95th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 47 | $42,307 |
| Dupixent SyringeDupilumab | 12 | $40,363 |
| XifaxanRifaximin | 12 | $38,515 |
| JardianceEmpagliflozin | 22 | $34,237 |
| RybelsusSemaglutide | 19 | $29,521 |
| OzempicSemaglutide | 18 | $29,389 |
| Xigduo XrDapaglifloz Propaned/Metformin | 22 | $23,879 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $22,108 |
| MounjaroTirzepatide | 22 | $21,534 |
| KerendiaFinerenone | 19 | $21,427 |
| VraylarCariprazine Hcl | 13 | $16,319 |
| Icosapent Ethyl | 19 | $12,817 |
| Bydureon BciseExenatide Microspheres | 16 | $11,709 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $8,875 |
| NexiumEsomeprazole Magnesium | 15 | $7,305 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $2,222 | $58,91037 claims |
| AstraZenecaFarxiga, Nexium | $3,132 | $49,61162 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $492 | $43,11233 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $491 | $38,51512 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $399 | $26,06934 claims |
| Lilly USA, LLCMounjaro | $607 | $21,53422 claims |
| BayerKerendia | $679 | $21,42719 claims |
| AbbVieVraylar, Synthroid | $1,937 | $17,73352 claims |
| Arbor Pharmaceuticals, Inc.Edarbi | $692 | $5,82313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Lake Hopatcong
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.